| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO
1 company
Finizio Robert G is a CEO at TherapeuticsMD, Inc.. Recent SEC Form 4 filings include 7 buys and 9 sells.
Estimated insider holdings value: $36.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2021 | TXMD Therapeuticsmd, Inc. | CEO | Sale+OE | 67,697 | $1.04 | $70,404.88 | -0.4% | -8.4% | -93.3% | |
| Jun 9, 2020 | TXMD Therapeuticsmd, Inc. | CEO | Buy | 46,000 | $1.44 | $66,360.00 | +0.1% | - | - | |
| Jun 5, 2020 | TXMD Therapeuticsmd, Inc. | CEO | Buy | 30,000 | $1.15 | $34,600.00 | - | - | - | |
| Oct 25, 2019 | TXMD Therapeuticsmd, Inc. | CEO | Buy | 72,000 | $2.75 | $198,000.00 | +0.4% | - | - | |
| Aug 20, 2019 | TXMD Therapeuticsmd, Inc. | CEO | Buy | 35,000 | $2.74 | $95,900.00 | +0.2% | - | - | |
| Aug 9, 2019 | TXMD Therapeuticsmd, Inc. | CEO | Buy | 52,405 | $2.96 | $155,118.80 | +0.3% | - | - | |
| Dec 20, 2018 | TXMD Therapeuticsmd, Inc. | CEO | Sale+OE | 184,910 | $3.66 | $677,107.66 | -0.5% | - | - | |
| Dec 7, 2018 | TXMD Therapeuticsmd, Inc. | CEO | Sale+OE | 184,000 | $4.59 | $844,192.00 | -0.5% | - | - | |
| Nov 27, 2018 | TXMD Therapeuticsmd, Inc. | CEO | Sale+OE | 184,000 | $4.83 | $889,088.00 | -0.5% | - | - | |
| Nov 13, 2018 | TXMD Therapeuticsmd, Inc. | CEO | Sale+OE | 184,000 | $4.77 | $877,588.00 | -0.5% | - | - |